Because DNA damage represents a formidable challenge to the integrity of genetic material, cells have evolved multifaceted systems, collectively termed the DNA-damage response (DDR), to detect, signal and repair various types of DNA damage 1,2 . DNA double-strand breaks (DSBs) represent one of the most challenging forms of DNA damage which, if left unrepaired, can trigger cell death and contribute to human diseases, including cancer 1 . In eukaryotes, DSBs are repaired by two main pathways: nonhomologous end-joining (NHEJ), which operates throughout the cell cycle, and homologous recombination, which is limited to the S and G2 phases of the cell cycle 3 . For NHEJ, the Ku70-Ku80 complex loads onto free DNA ends where it helps recruit the DDR protein kinase DNA-dependent protein kinase (DNA-PK) 4 as well as other factors, including the nuclease Artemis and the Ligase IV-XRCC4 complex, which are required for NHEJ to ensue 5 . NHEJ occurs rapidly in cells and mostly requires minimal processing of DNA ends. By contrast, homologous recombination requires extensive DNA-end resection to create stretches of single-stranded DNA (ssDNA) that acts as a substrate for the single-stranded DNA binding factor RPA and the recombinase RAD51 that are required for various steps in homologous recombination 3 . As homologous recombination and NHEJ function together during certain phases of the cell cycle, mechanisms must exist to select a repair pathway for each DSB. Although both DNAend resection and the cell cycle-dependent phosphorylations regulate DSB repair pathway use, it is tempting to speculate that the chromatin context of a DSB will also influence whether it is repaired by NHEJ or homologous recombination.
a r t i c l e s
Because DNA damage represents a formidable challenge to the integrity of genetic material, cells have evolved multifaceted systems, collectively termed the DNA-damage response (DDR), to detect, signal and repair various types of DNA damage 1, 2 . DNA double-strand breaks (DSBs) represent one of the most challenging forms of DNA damage which, if left unrepaired, can trigger cell death and contribute to human diseases, including cancer 1 . In eukaryotes, DSBs are repaired by two main pathways: nonhomologous end-joining (NHEJ), which operates throughout the cell cycle, and homologous recombination, which is limited to the S and G2 phases of the cell cycle 3 . For NHEJ, the Ku70-Ku80 complex loads onto free DNA ends where it helps recruit the DDR protein kinase DNA-dependent protein kinase (DNA-PK) 4 as well as other factors, including the nuclease Artemis and the Ligase IV-XRCC4 complex, which are required for NHEJ to ensue 5 . NHEJ occurs rapidly in cells and mostly requires minimal processing of DNA ends. By contrast, homologous recombination requires extensive DNA-end resection to create stretches of single-stranded DNA (ssDNA) that acts as a substrate for the single-stranded DNA binding factor RPA and the recombinase RAD51 that are required for various steps in homologous recombination 3 . As homologous recombination and NHEJ function together during certain phases of the cell cycle, mechanisms must exist to select a repair pathway for each DSB. Although both DNAend resection and the cell cycle-dependent phosphorylations regulate DSB repair pathway use, it is tempting to speculate that the chromatin context of a DSB will also influence whether it is repaired by NHEJ or homologous recombination.
It is becoming increasingly clear that, as well as exerting profound effects on transcription, chromatin structure markedly influences DNA-damage recognition, signaling and repair [6] [7] [8] . Histones, the basic protein units of chromatin, are subjected to modifications such as acetylation, phosphorylation and ubiquitylation that can alter the properties of chromatin and thereby influence DNA-based processes, including DNA-damage responses 9 . For instance, activation of the apical DDR protein kinases ataxia telangiectasia mutated (ATM), ATM and Rad3 related (ATR) and DNA-PK leads to phosphorylation of the histone variant H2AX on chromatin flanking DSB sites 10 . This phosphorylated form of H2AX, termed γH2AX, is one of the earliest chromatin markers of DSBs and is essential for the accumulation of repair and signaling proteins, such as 53BP1, into foci at DNA-damage sites [6] [7] [8] 11 . Likewise, the recruitment of the ubiquitin E3 ligases RNF8 and RNF168 to DSB sites mediates histone H2A and H2AX ubiquitylation, which is vital for effective execution of the DDR [12] [13] [14] [15] [16] . Histone acetylations, together with the enzymes that mediate their addition and removal, have also been implicated in the DDR, although their modes of action are less well defined than those of histone phosphorylations and ubiquitylations [17] [18] [19] . A screen for DNA damage-responsive histone modifications in human cells showed that H3K9 and H3K56 acetylations (H3K9Ac and H3K56Ac) are negatively regulated by DNA damage 20 . However, other studies reported differential effects of DNA damage on H3K56Ac in mammalian cells [21] [22] [23] , and this highlights the need for additional analysis of H3K56Ac and its functions in mammalian cells.
Histone acetylations are regulated by the concerted actions of histone acetyltransferases (HATs) and histone deacetylases (HDACs) that work by adding and removing acetyl groups from lysine residues. Human cells contain 18 known HDACs that fall into four classes. Class I HDACs, which include HDAC1, HDAC2, HDAC3 and HDAC8, are most closely related to budding yeast Rpd3 (refs. 24, 25) . a r t i c l e s These HDACs are ubiquitously expressed and are mainly localized within the nucleus, where they function in diverse processes, including transcription. Class II HDACs consist of HDAC4-7, HDAC9 and HDAC10. These HDACs are most closely related to yeast Hda1, are not ubiquitously expressed and localize chiefly to the cytoplasm, although they can become nuclear through their regulation by 14-3-3 proteins and phosphorylation 25 . Class III HDACs, also known as sirtuins, are NAD dependent and consist of SIRT1-SIRT7, which are closely related to the yeast Sir2 protein 26 . Sirtuins can be nuclear or cytoplasmic and are involved in diverse processes including metabolism, transcription and the DDR. The HDAC class IV consists of only one member, HDAC11, whose functions are poorly understood. A key goal for studies on HDAC enzymes is to define their in vivo targets, as this can provide crucial insights into how these multitasking enzymes carry out their biological functions 26 . Such work is also of medical relevance, given that broad specificity HDAC inhibitors are promising anti-cancer drugs that can selectively kill cancer cells and are known to sensitize cells to treatments that induce DNA damage 24, 27, 28 .
The finding that H3K56Ac is decreased following DNA damage prompted us to evaluate the role of HDACs in the DDR. Here, we describe how human HDAC1 and HDAC2 respond to DNA damage and mediate changes in histone acetylation, including H3K56, after DNA damage. Furthermore, by defining the effects of impairing HDAC1 and HDAC2 function, we establish that these enzymes serve as important components of the DDR by promoting DSB signaling and repair, principally through their requirement for effective NHEJ.
RESULTS

HDAC1 and HDAC2 localize to sites of DNA damage
H3K56Ac is decreased by treatments that induce DNA damage, including the drug phleomycin, which produces DSBs 20 . Although damage-dependent H3K56Ac loss could occur through multiple mechanisms, we reasoned that it might reflect the action of one or more HDACs. Consequently, we tested whether levels of H3K56Ac and their reduction upon DNA damage were affected by the class I and II HDAC inhibitors trichostatin A (TSA) and sodium butyrate (NaB) or by the sirtuin inhibitor nicotinamide. In cells that had not been treated with a DNA-damaging agent, TSA and NaB, but not nicotinamide, increased levels of H3K56Ac (Fig. 1a) . This suggested that class I/II HDACs regulate H3K56Ac under normal growth conditions. Furthermore, whereas DNA damage resulted in decreased H3K56Ac in cells treated with no inhibitors or with nicotinamide, treatment with TSA or NaB prevented the DNA damage-induced decrease in H3K56Ac (Fig. 1a) . These data indicate that H3K56Ac levels are mainly controlled by class I/II HDACs and that the activity of such HDACs is also needed for H3K56Ac loss upon DNA-damage induction.
On the basis of the above results, we speculated that the HDAC(s) responsible for H3K56 deacetylation might be activated by DNA damage or localized to DNA-damage sites. Class I HDACs would be prime candidates for such factors, as these enzymes are mainly nuclear. When we screened all class I HDACs for their ability to localize to sites of laser-induced DNA damage, we detected the recruitment of endogenous HDAC1 and HDAC2, but not HDAC3 or HDAC8, to sites of laser microirradiation with commercially available antibodies ( Fig. 1b; antibody specificities for HDAC1 and HDAC2 are verified in Supplementary Fig. 1 ). The accumulation of HDAC1 and HDAC2 occurred within 5 min of DNA damage and then gradually declined, being no longer detectable after 30 min (Fig. 1b and data not shown) . Consistent with HDAC1 and HDAC2 functioning at DNA damage sites, staining for H3K56Ac was diminished at sites of DNA damage containing γH2AX (Fig. 1c and Supplementary Fig. 2a ; compare the dotted lines representing average H3K56Ac intensities in damaged and undamaged regions). By contrast, other histone acetylations that we analyzed did not change detectably in response to laser microirradiation (Supplementary Fig. 2e ). By using immunofluorescence to detect irradiation-induced foci (IRIF), we found that H3K56Ac 
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Quantification of H3K56Ac intensities showed that this modification was lower in damaged regions (IRIF) than in undamaged regions ( Supplementary Fig. 2b,c) .
H3K56Ac is decreased after DNA damage
To analyze the behavior of H3K56Ac at site-specific DNA breaks, as well as to complement our western blotting and immunofluorescence data, we used a U2OS cell line expressing a 4-hydroxytamoxifen (4-OHT)-inducible restriction enzyme (AsiSI-ER) that causes DSBs at specific genomic loci 29 (see Supplementary Fig. 3 for confirmation of DNA-damage induction by 4-OHT addition, which induced γH2AX and 53BP1 foci). By using chromatin immunoprecipitation (ChIP) analysis, we found that induction of AsiSI-ER decreased H3K56Ac at DSB sites, but there was no reduction at another site that did not contain an AsiSI sequence ( Fig. 1d ; note that the effects on H3K56Ac are specific because H3K14Ac did not decrease at either DSB site, whereas γH2AX was increased). Together, these results established that H3K56Ac is decreased at sites of DNA damage. As HDAC1 and HDAC2 localize to sites of laser microirradiation, and because H3K56Ac is lost at such sites, we next determined whether HDAC inhibitors could block the localized decrease of H3K56Ac in damaged regions. Class I/II HDAC inhibitors suppressed H3K56 deacetylation at sites of laser microirradiation and also blocked the localization of HDAC1 and HDAC2 to DNAdamage regions (Fig. 1e) . These data suggest that HDAC1/2 regulate H3K56Ac and deacetylate H3K56 at sites of DNA damage through their localization to damaged DNA by an HDAC inhibitor-sensitive process.
DNA is damaged not only by exogenously applied agents but also when cells enter oncogene-induced senescence (OIS) or replicative senescence [30] [31] [32] . Human diploid fibroblasts showing OIS as a result of RAS overexpression [32] [33] [34] contained less H3K56Ac than control cells, and H3K56Ac was excluded from DNA-damage sites in these fibroblasts (Fig. 2a,b) . Similarly, late-passage human diploid fibroblasts showing replicative senescence contained less H3K56Ac than did earlierpassage cells (Fig. 2c,d and Supplementary  Fig. 4a ). The observed decrease in H3K56Ac was not due to effects of DNA damage on cell-cycle distributions, as this histone mark is not cellcycle regulated 20, 35 (Supplementary Fig. 4b ).
During the course of the above studies, we found that H4K16Ac was reduced by replicative senescence but enhanced upon OIS. Furthermore, by carrying out laser microirradiation studies, we found that H4K16Ac showed a biphasic response at DNA-damage sites, being reduced at early time points (Fig. 2e ) but enhanced at later times (Fig. 2f) . The kinetics of H4K16Ac loss were similar to those of H3K56Ac loss by both IRIF (Supplementary Fig. 2b ) and at sites of laser microirradiation ( Supplementary Fig. 4c ). Our interpretation of these data is that, although both H3K56Ac and H4K16Ac signals are rapidly lost at DNA-damage sites, H4K16Ac levels then increase at damaged regions as a consequence of ongoing DNA repair. This would also explain the differential effects seen for H4K16Ac in senescent cells because increased H4K16Ac could reflect ongoing DNA repair during OIS but not during replicative senescence. The above findings thereby establish that H3K56Ac levels are decreased by both exogenous and endogenously produced DNA damage and indicate that H4K16Ac is also a DNA damageresponsive histone mark.
HDAC1 and HDAC2 deacetylate H3K56 and H4K16
As HDAC1 is implicated in cellular senescence 36, 37 , and given the similar kinetics between recruitment of HDAC1 and HDAC2 to DNA damage sites and the loss of H3K56 and H4K16 acetylation at sites of damage, we tested whether HDAC1 and HDAC2 regulated these histone marks. Depletion of HDAC1 and HDAC2 together (HDAC1/2) by small inhibitory RNA (siRNA), but not of either alone, caused hyperacetylation of H3K56 and H4K16 in U2OS cells ( Fig. 3a; as shown in Supplementary Fig. 5a ,b, HDAC1/2 depletion did not appreciably affect cell-cycle distributions). Depletion of HDAC1 and HDAC2 in HeLa cells also resulted in hyperacetylation of H3K56Ac, detected by two anti-H3K56Ac antibodies ( Fig. 3b; see below) . By contrast, depletion of HDAC3, which was not detectably recruited to DNA-damage sites, did not cause hyperacetylation of H3K56Ac or H4K16Ac (Fig. 3c) . We carried out various experiments to verify that the observed effects reflected depletion of HDAC1 and HDAC2 rather than off-target effects. We also observed induction of H3K56Ac and H4K16Ac when we used pairwise combinations of various HDAC1-and HDAC2-targeting siRNA oligonucleotides (Supplementary Fig. 5c ). 
a r t i c l e s
Furthermore, the effects of HDAC1/2 depletion on H3K56Ac and H4K16Ac levels were circumvented when we used a siRNA-resistant HDAC1 derivative (Fig. 4a) . For this analysis, we created a cell line that expressed a form of HDAC1 (siResA-HDAC1) that was resistant to HDAC1 siRNA A. We found that siResA-HDAC1 rescued the hyperacetylation of H3K56 and H4K16 in cells depleted of endogenous HDAC1 by siRNA A but did not rescue H3K56 hyperacetyation caused by another HDAC1 siRNA (B) that targets both endogenous HDAC1 and siResA-HDAC1. We found similar effects in immunofluorescence experiments, where cells expressing green fluorescent protein (GFP)-tagged siResA-HDAC1 contained less H3K56Ac than those lacking HDAC1 ( Fig. 4b ; only one siRNA-resistant construct was required because, as shown in Supplementary Fig. 5d , depletion of HDAC1 or HDAC2 alone did not result in hyperacetylation of H3K56).
Of the acetylations we tested, H3K56Ac and H4K16Ac increased most in HDAC1/2-depleted cells, confirming that they are targets of HDAC1 and HDAC2 (Fig. 4c) . Furthermore, recombinant HDAC1 deacetylated these sites on calf histones in vitro, suggesting that H3K56Ac and H4K16Ac are direct targets of HDAC1 and HDAC2 (Fig. 4d) . Consistent with this, treating cells with the class I and II HDAC inhibitors TSA or NaB enhanced both H3K56Ac and H4K16Ac (Supplementary Fig. 5e ). In yeast, H3K56Ac is deacetylated by sirtuins, which have also been implicated in H3K56Ac deacetylation in mammals 22, 38, 39 . However, when we treated cells with the sirtuin inhibitor nicotinamide or depleted cells of SIRT1 and SIRT2, we found little or no increase in H3K56Ac or H4K16Ac (Fig. 4e and  Supplementary Fig. 5f ; analysis of p53 acetylation, a known sirtuin target 40, 41 , showed that nicotinamide was effective in our assays). Nevertheless, SIRT6 depletion has been shown to enhance H3K56Ac specifically at telomeres 21 , and knockout of SIRT6 or depletion of HDAC1/2 in mouse cells results in increased H3K56Ac 23, 42 . Our data show that levels of H3K56Ac and H4K16Ac are mainly controlled by HDAC1 and HDAC2 in human cells and highlight how regulation of H3K56Ac can differ between organisms and genomic locations.
HDAC1 and HDAC2 are required for the DDR
During the above work, we noted that, although depletion of HDAC1 and HDAC2 on its own triggered only nominal γH2AX production, it reproducibly enhanced the levels of γ H2AX produced in phleomycintreated cells ( Fig. 3b; see also below) . This observation, with the localization of HDAC1 and HDAC2 to sites of DNA damage, suggested that these HDACs have functional roles in the DDR. Consistent with this idea, depletion of HDAC1 and HDAC2 caused hypersensitivity to the DSB-inducing agents ionizing radiation and phleomycin (Fig. 5a) . While ns, nonspecific. siRNA sequences targeting SIRT1 and SIRT2 were obtained from a previous study 22 . Lower right panel, fluorescence microscopy confirms the documented cytoplasmic localization of SIRT2 and the efficient depletion of GFP-SIRT2. Scale bar, 10 μm.
a r t i c l e s investigating the molecular basis for these phenotypes, we found that depletion of HDAC1 and HDAC2 or treatment with HDAC inhibitors led to the production of more γH2AX in response to DNA damage than in control cells (Figs. 1a and 5b and Supplementary Fig. 6a-d ; as shown in Supplementary Fig. 7a -c, these phenotypes were rescued when we complemented cells with a siRNA-resistant HDAC1). Furthermore, DNA damage-induced phosphorylations of the checkpoint kinases CHK1 and CHK2 and the tumor suppressor p53 were also higher and more sustained in cells depleted of HDAC1 and HDAC2 than in control cells (Fig. 5b) . Inhibition of HDAC1 and HDAC2 also enhanced the amount of γH2AX at a site-specific DSB detected by ChIP analysis (see below). These data suggest that depletion or inhibition of HDAC1 and HDAC2 does not affect the amount of DNA damage produced by DSB-inducing agents but, rather, impairs DNA repair. Consistent with this idea, and in contradiction of the idea that depletion of HDAC1 and HDAC2 causes indirect transcriptional effects, treatment of cells with DNA-damaging agents followed by immediate addition of HDAC inhibitors also resulted in hyperphosphorylation of γ H2AX (Fig. 5c) . Moreover, by using comet assays, we established that, although the levels of endogenous and induced DSBs were similar in control cells and those depleted of HDAC1 and HDAC2, the repair of ionizing radiationand phleomycin-induced DSBs was markedly impaired by depletion a r t i c l e s of HDAC1 and HDAC2 (Fig. 5d-f) . Furthermore, cells depleted of HDAC1 and HDAC2 showed defective DSB repair as revealed by a modest reduction in homologous recombination measured by a I-Sce1-based homologous recombination assay as well as a substantial defect in NHEJ measured by random-plasmid integration ( Fig. 6a,b ; as shown in Supplementary Fig. 7d , cells depleted of HDAC1 and HDAC2 expressed normal levels of core NHEJ factors, which rules out indirect transcriptional effects). In addition, depletion of HDAC1 and HDAC2 led to an increase in DNA-damage induced auto-phosphorylation (S2056p) and ATM-mediated phosphorylation (T2609p) of the NHEJ factor DNA-PKcs (Fig. 6c) . By contrast, depletion of HDAC1 and HDAC2 did not markedly affect the induction of DDR markers when cells were treated with camptothecin (Fig. 6d) , which produces DSBs in S phase that are repaired by homologous recombination 43 . These data therefore indicate that HDAC1 and HDAC2 promote proper DSB signaling and repair, predominantly through their requirement for effective NHEJ.
HDACs influence NHEJ factor persistence at DSBs
Finally, we used live-cell imaging to determine whether HDAC1 and HDAC2 affected the recruitment or persistence of the NHEJ factors Ku70 and Artemis at sites of DNA damage 44, 45 . GFP-Ku70 and Artemis were rapidly recruited to sites of laser-induced DNA damage ( Fig. 7a,b ; bright staining of GFP-Ku70 under all conditions reflects nucleolar localization, as reported 46 ). Both Ku70 and Artemis showed increased association with damaged regions in cells treated with HDAC inhibitors, compared with control cells (Fig. 7a-c) . Furthermore, depletion of HDAC1 and HDAC2 produced similar results (Fig. 7d) .
Because NHEJ factors persist at DSB sites under conditions of defective NHEJ 44 , these data were consistent with the idea that depletion of HDAC1 and HDAC2 renders cells defective in NHEJ. However, we do not think that these data solely reflect a NHEJ defect because the persistence of Artemis at sites of DNA damage was greater in cells depleted of HDAC1 and HDAC2 than in those depleted of Ligase IV (Fig. 7d) , even though Ligase IV depletion causes an equal, if not greater, NHEJ deficiency than depletion of HDAC1 and HDAC2 (Fig. 6b) . In corroboration with these findings, using ChIP analyses, we found that HDAC inhibitors caused the NHEJ factors Ku70/80 and XRCC4 to show enhanced association with an AsiSI-ER-induced, site-specific DSB (Fig. 7e) . Our results thereby show that HDAC1 and HDAC2 promote NHEJ, at least in part by regulating the proper assembly or disassembly (or both) of NHEJ factors from DSB sites. 
DISCUSSION
Our data support a model in which protein deacetylations mediated by HDAC1 and HDAC2, including those on H3K56 and H4K16, promote DSB repair, particularly NHEJ (Fig. 8) . Such a model has resonance with the situation in budding yeast, where mutation of H4K16 or deletion of the HDAC1/2 homolog Rpd3 renders cells NHEJ-defective and deacetylation of H4K16 occurs at DSBs 47, 48 . Furthermore, H3K56Ac in yeast is absent in G1, when NHEJ is most active, and is highest in S phase, when homologous recombination predominates, and H3K56 hyperacetylation in G1 is detrimental to genome stability 39, 49 . Although such findings might initially seem at odds with work showing that histone hyperacetylation occurs at DNA-damage sites, such increases in H4 acetylation were detected only at late times after DSB induction, and that HDAC inhibitors were found to enhance the loading of Rad51, a homologous recombination protein 19 . Consequently, we suggest that changes in histone acetylation are likely to occur in a biphasic manner after DSB induction, with rapid deacetylation on sites such as H3K56 and H4K16 occurring to promote NHEJ (possibly by generating a less dynamic, 'repressed' chromatin state) being followed by histone acetylations that enhance homologous recombination (and potentially alternative NHEJ pathways) by making chromatin more 'open' . Thus, as for transcription, HDACs and HATs might function in a coordinated manner in the DDR to promote both open and repressed chromatin states to facilitate distinct events 50 . There are various ways in which HDAC1 and HDAC2 could influence NHEJ. One possibility is that transcription is inhibited at sites of DNA damage, and rapid histone deacetylation by HDAC1 and HADC2 at sites of DNA damage represses transcription, thereby preventing transcription from interfering with repair processes. Histone hypoacetylation is generally associated with transcriptionally silent chromatin, and H3K56Ac and H4K16Ac are histone marks that are associated with transcriptional activation 35, 51 . Consistent with HDAC1 and HDAC2 being recruited to sites of DNA damage as components of transcriptional corepressor complexes (such as NuRD, Sin3 and CoREST), at sites of laser microirradiation, we also found hypophosphorylation of RNA polymerase II Serine-5, as well as ubiquitylated histone H2A and SUMO1, three markers that are all associated with transcriptional repression 14, 52 (Supplementary Fig. 8 ). An additional way in which HDAC1 and HDAC2 could promote NHEJ is to affect the ability of NHEJ factors to bind DSB sites or to function effectively there. In vitro studies have shown that, although Ku can bind and slide freely on naked DNA, nucleosomes can act as a barrier to such sliding 53 . Therefore, HDAC1and HDAC2 could alter chromatin into a state that promotes NHEJ, at least in part by restraining unproductive Ku sliding and instead maintaining Ku at DSB termini to mediate repair. In this regard, the enhanced accrual of Ku and Artemis at sites of DNA damage that, upon inactivation of HDAC1 and HDAC2, is not only due to impaired NHEJ but also reflects the NHEJ machinery unproductively spreading onto chromatin flanking the DSB sites. We cannot rule out the possibility that, as well as deacetylating histones, HDAC1 and HDAC2 more directly influence DSB repair by targeting NHEJ factors themselves or other regulators, such as ATM, that might be important for NHEJ in particular chromatin contexts [54] [55] [56] . Clearly, studies that aim to systematically identify HDAC1 and HDAC2 substrates will be valuable in exploring such possibilities.
DNA damage is induced during tumor evolution 57, 58 , and HDAC1 and HDAC2 are overexpressed in many cancers 24 , possibly to promote effective DNA repair by regulating histone acetylations, including H4K16Ac 59 . Furthermore, broad-specificity HDAC inhibitors are promising anti-cancer drugs that sensitize cancer cells to DNA-damaging treatments 24, 27, 28 . Hypoacetylated histones in cancer cells can epigenetically silence tumor-suppressor genes (including p21), and HDAC inhibitors can reverse this silencing, leading to cell-cycle arrest 24, 60 . However, the specific HDACs whose inhibition results in these effects, as well as their targets, have not yet been identified. Our data highlight the potential for HDAC1 and HDAC2 and their targets, H3K56Ac and H4K16Ac, to be involved, through their impact on NHEJ, in modulating a cancer cell's susceptibility to HDAC inhibitors and DNA damagebased therapies. Finally, we speculate that, although broad-specificity HDAC inhibitors are used for cancer treatments and are being combined with radiotherapies in clinical trials 28 , specific coinhibition of HDAC1 and HDAC2 would be effective in such contexts.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Cell culture, reagents and treatments. Cells were maintained as described in Supplementary Methods. Phleomycin treatments used 60 µg ml −1 for 2 h unless stated otherwise. Cells were exposed to ionized radiation delivered by a Faxitron X-ray unit. Unless indicated otherwise, HDAC inhibitors were added for 16-24 h and final concentrations were as follows: sodium butyrate, 5 mM; TSA, 1.3 µM; nicotinamide, 25 mM. Antibodies used in this study are listed in Supplementary  Table 1 . Details of HDAC1 complementation and analysis of NHEJ factors are described in Supplementary Methods. Laser microirradiation. Laser microirradiation is described in detail in Supplementary Methods. Protein extracts and western blotting. For whole cell extracts, cells were washed once with PBS (phosphate buffered saline), collected by adding Laemmli buffer (4% (v/v) SDS, 20% (v/v) glycerol and 120 mM Tris, pH 6.8), incubated for 5 min at 95 °C, sheared through a 23-gauge needle and incubated again before loading. Samples were resolved by SDS-PAGE and analyzed by standard western blotting techniques. Antigens were detected by standard chemiluminescence (ECL; Amersham) or quantified with a LI-COR Odyssey infrared imaging system (LI-COR Biosciences). Secondary antibodies used for ECL were goat anti-rabbit HRP (Perbio Science) and rabbit anti-mouse HRP (Dako) antibodies. Secondary antibodies used for quantification were IRDye 680CW Donkey anti-rabbit or anti-mouse (LI-COR Biosciences).
siRNA transfection. RNA interference was performed as described 20 . Briefly, cells were subjected to two rounds of siRNA transfection with the indicated siRNAs using Qiagen HiPerFect (following the manufacturer's protocol), and after 72 h, cells were processed and analyzed as described for each experiment. siRNA sequences used in this study are listed in Supplementary Methods. Western blot analyses with the indicated antibodies were performed to analyze depletion efficiencies for each siRNA. For human SIRT2, siRNA depletion was tested on GFP-SIRT2 (cloned into eGFP-C1) that was transiently transfected into U2OS cells, followed by two rounds of siRNA with the indicated siRNAs against SIRT2.
Immunofluorescence analyses. Cells were grown on poly-L-lysine-treated coverslips. After indicated treatments, coverslips were washed once with PBS at 25 °C. Cells were pre-extracted by incubating coverslips in CSK buffer (10 mM PIPES, pH 6.8, 100 NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, 0.5% (v/v) Triton X-100) for 5 min on ice. Cells were washed once in cold PBS and fixed with 2% (v/v) paraformaldehyde (PFA) for 20 min at room temperature 22 °C followed by three washes with PBS-T (PBS containing 0.1% (v/v) Tween-20) and subsequently blocked for 15 min at room temperature in blocking buffer (PBS containing 3% BSA). Primary antibodies were incubated for 1 h at room temperature in the same buffer. Cells were then washed three times in PBS-T before incubation in the dark with Alexa Fluor-conjugated secondary antibodies (Molecular Probes) in blocking buffer for 45 min at room temperature. Cells were again washed three times in PBS-T followed by a final wash in PBS. The coverslips were then mounted on slides in Vectashield containing 4′,6-diamidino-2-phenylindole (Vector laboratories). Cells were imaged with an inverted FV1000 confocal microscope (Olympus) or a Radiance confocal microscope (BioRad). Quantitative analyses of intensities versus distance for immunofluorescence images were obtained with the line-intensity function by using Volocity software (Improvision). For BrdU labeling combined with dual immunofluorescence, cells were grown on coverslips and incubated with 10 mM BrdU for 20 min. Coverslips were pre-extracted and processed for immunofluorescence for either H3K56Ac or γ H2AX. DNA-damage analysis with BrdU is described in Supplementary Methods. Chromatin immunoprecipitation analysis. U2OS cells containing a stably integrated AsiSI-ER-PURO construct were grown in selective medium (1 µg ml −1 puromycin). To induce the nuclear expression of AsiSI-ER, these cells were treated with 300 nM of 4-OHT (4-hydroxytamoxifen) for 4 h to induce sitespecific DSBs. Cells were untreated or treated with 4-OHT and analyzed by ChIP as described in Supplementary Methods. To ChIP NHEJ factors, experiments were done essentially as described for Figure 1d with the following exceptions. Cells were either untreated or treated with sodium butyrate (5 mM) for 16 h. Cells were then pre-treated with DNA-PKcs inhibitor (NU7441, 10 µM) for 1 h followed by 4-OHT (300 nM) for 2 h. Antibodies and primer sequences are given in Supplementary Methods.
